Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Image processing tools for the validation of CryoEM maps

  • Sorzano, C. O. S.
  • Muñoz Barrutia, María Arrate
Documento escrito por un elevado número de autores/as, solo se referencia el/la que aparece en primer lugar y los/as autores/as pertenecientes a la UC3M., Correction: The authors regret the omission of one of the authors, Federico de Isidro Gómez, from the original manuscript. The corrected list of authors and affiliations for this paper is as shown above. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers. (Faraday Discuss., 2022,240, 228-228. https://doi.org/10.1039/D2FD90074B), The number of maps deposited in public databases (Electron Microscopy Data Bank, EMDB) determined by cryo-electron microscopy has quickly grown in recent years. With this rapid growth, it is critical to guarantee their quality. So far, map validation has primarily focused on the agreement between maps and models. From the image processing perspective, the validation has been mostly restricted to using two half-maps and the measurement of their internal consistency. In this article, we suggest that map validation can be taken much further from the point of view of image processing if 2D classes, particles, angles, coordinates, defoci, and micrographs are also provided. We present a progressive validation scheme that qualifies a result validation status from 0 to 5 and offers three optional qualifiers (A, W, and O) that can be added. The simplest validation state is 0, while the most complete would be 5AWO. This scheme has been implemented in a website https://biocomp.cnb.csic.es/EMValidationService/ to which reconstructed maps and their ESI can be uploaded., Javier Vargas and Jordi Burguet would like to thank the Spanish Ministry of Science and Innovation for financial support through the call 2019 Proyectos de I+D+i - RTI Tipo A (PID2019108850RA-I00) and Arrate Muñoz Barrutia, PID2019-109820RB-I00, MCIN/AEI/ 10.13039/501100011033/, cofinanced by European Regional Development Fund (ERDF), A way of making Europe. The authors acknowledge the economic support from MICIN of the Instruct Image Processing Center (I2PC) as part of the Spanish participation in Instruct-ERIC, the European Strategic Infrastructure Project (ESFRI) in the area of Structural Biology, Grant PID2019-104757RB-I00 funded by MCIN/AEI/10.13039/501100011033/ and ERDF A way of making Europe, by the European Union and Grant PRE2020-093527 funded by MCIN/ AEI/ 10.13039/501100011033 and by ESF Investing in your future. We also acknowledge support from Comunidad Autónoma de Madrid through Grant: S2017/BMD-3817, Instituto de Salud Carlos III (project IMPaCT-Data, exp. IMP/ 00019), co-funded by the European Union, European Regional Development Fund (ERDF, A way to make Europe), and European Union (EU) and Horizon 2020 through grants: EOSC Life (INFRAEOSC-04-2018, Proposal: 824087), HighResCells (ERC- 2018- SyG, Proposal: 810057), IMpaCT (WIDESPREAD-03-2018Proposal: 857203), EOSC- Synergy (EINFRA-EOSC-5, Proposal: 857647), iNEXTDiscovery (Proposal: 871037), EnLaCES (H2020-MSCA-IF-2020, Proposal: 101024130).
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Advances in xmipp for cryo-electron microscopy: From xmipp to scipion

  • Strelak, David
  • Jiménez-Moreno, Amaya
  • Vilas, José L.
  • Ramírez-Aportela, Erney
  • Sánchez-García, Rubén
  • Maluenda Niubó, David
Xmipp is an open-source software package consisting of multiple programs for processing data originating from electron microscopy and electron tomography, designed and managed by the Biocomputing Unit of the Spanish National Center for Biotechnology, although with contributions from many other developers over the world. During its 25 years of existence, Xmipp underwent multiple changes and updates. While there were many publications related to new programs and functionality added to Xmipp, there is no single publication on the Xmipp as a package since 2013. In this article, we give an overview of the changes and new work since 2013, describe technologies and techniques used during the development, and take a peek at the future of the package.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

  • Ginex, Tiziana
  • Marco Marín, Clara
  • Wieczór, Miłosz
  • Mata, Carlos P.
  • Krieger, James
  • Ruiz Rodriguez, Paula
  • López Redondo, Maria Luisa
  • Francés Gómez, Clara
  • Melero, Roberto
  • Sánchez Sorzano, Carlos Óscar
  • Martínez, Marta
  • Gougeard, Nadine
  • Forcada Nadal, Alicia
  • Zamora Caballero, Sara
  • Gozalbo Rovira, Roberto
  • Sanz Frasquet, Carla
  • Arranz, Rocío
  • Bravo, Jeronimo
  • Rubio, Vicente
  • Marina, Alberto
  • Geller, Ron
  • Comas, Iñaki
  • Gil, Carmen
  • Coscolla, Mireia
  • Orozco López, Modesto
  • Llácer, José Luis
  • Carazo, Jose Maria
  • The IBV Covid19 Pipeline
The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has since reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multitarget Virtual Screening for Drug Repurposing in COVID19

  • Sorzano, Carlos Óscar S.
  • Crisman, Enrique
  • Carazo, José M.
  • León, Rafael
Therapeutic or preventive research for coronavirus SARS-CoV2 is an extremely active topic of research since its outbreak in January 2020. In this paper we report the results from a virtual drug screening analysis that, to the best of our knowledge, is the widest work in terms of target proteins and compound library. Our study was focused on the repur- posing of currently commercialized drugs, and especially those that can interact with multiple viral proteins and several binding sites within each protein. Additionally, we performed a second virtual screening analysis in which we compared our results to the predicted binding a nities for the drugs currently in clinical trials. We show that the best molecules in our screening compares favourably to those in clinical trials, suggesting their suitability for therapeutic or preventive applications.Therapeutic or preventive research for coronavirus SARS-CoV2 is an extremely active topic of research since its outbreak in January 2020. In this paper we report the results from a virtual drug screening analysis that, to the best of our knowledge, is the widest work in terms of target proteins and compound library. Our study was focused on the repur- posing of currently commercialized drugs, and especially those that can interact with multiple viral proteins and several binding sites within each protein. Additionally, we performed a second virtual screening analysis in which we compared our results to the predicted binding a nities for the drugs currently in clinical trials. We show that the best molecules in our screening compares favourably to those in clinical trials, suggesting their suitability for therapeutic or preventive applications., We thank nancial support from the Spanish Ministry of Economy and Competitiveness through Grants BIO2016-76400-R(AEI/FEDER, UE), the \Comunidad Autonoma de Madrid" through Grant: S2017/BMD-3817, Instituto de Salud Carlos III, PT17/0009/0010 (ISCIII-SGEFI/ERDF), European Union (EU) and Horizon 2020 through grants: CORBEL (INFRADEV-1-2014-1, Proposal: 654248), INSTRUCT-ULTRA (INFRADEV-03-2016-2017, Proposal: 731005), EOSC Life (INFRAEOSC-04-2018, Proposal: 824087), HighResCells (ERC- 2018-SyG, Proposal: 810057), IMpaCT (WIDESPREAD-03-2018 - Proposal: 857203), EOSC-Synergy (EINFRA-EOSC-5, Proposal: 857647), and iNEXTDiscovery (Proposal: 871037). The authors acknowledge the support and the use of resources of Instruct, a Landmark ESFRI project., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Improvements on marker-free images alignment for electron tomography

  • Sorzano, Carlos Óscar S.
  • Isidro, Federico de
  • Fernández-Giménez, Elena
  • Herreros, David
  • Marco, Sergio
  • Carazo, José M.
  • Messaoudi, C.
© 2020 The Author(s)., Electron tomography is a technique to obtain three-dimensional structural information of samples. However, the technique is limited by shifts occurring during acquisition that need to be corrected before the reconstruction process. In 2009, we proposed an approach for post-acquisition alignment of tilt series images. This approach was marker-free, based on patch tracking and integrated in free software. Here, we present improvements to the method to make it more reliable, stable and accurate. In addition, we modified the image formation model underlying the alignment procedure to include different deformations occurring during acquisition. We propose a new way to correct these computed deformations to obtain reconstructions with reduced artifacts. The new approach has demonstrated to improve the quality of the final 3D reconstruction, giving access to better defined structures for different transmission electron tomography methods: resin embedded STEM-tomography and cryo-TEM tomography. The method is freely available in TomoJ software., We thank financial support from the Spanish Ministry of Economy and Competitiveness through Grants BIO2016-76400-R(AEI/FEDER, UE), the “Comunidad Autónoma de Madrid” through Grant: S2017/BMD-3817, Instituto de Salud Carlos III, PT17/0009/0010 (ISCIII-SGEFI/ERDF), European Union (EU) and Horizon 2020 through grants: CORBEL (INFRADEV-1–2014-1, Proposal: 654248), INSTRUCT-ULTRA (INFRADEV-03–2016-2017, Proposal: 731005), EOSC Life (INFRAEOSC-04–2018, Proposal: 824087), HighResCells (ERC-2018-SyG, Proposal: 810057), IMpaCT (WIDESPREAD-03–2018 - Proposal: 857203), EOSC-Synergy (EINFRA-EOSC-5, Proposal: 857647), and iNEXT-Discovery (Proposal: 871037). The authors acknowledge the support and the use of resources of Instruct, a Landmark ESFRI project.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications

  • Altincekic, Nadide
  • Korn, Sophie Marianne
  • Qureshi, Nusrat Shahin
  • Dujardin, Marie
  • Ninot-Pedrosa, Martí
  • Abele, Rupert
  • Abi Saad, Marie Jose
  • Alfano, Caterina
  • Almeida, Fabio C. L.
  • Alshamleh, Islam
  • Cardoso de Amorim, Gisele
  • Anorma, Chelsea
  • Bains, Jasleen Kaur
  • Bax, Andriaan
  • Blackledge, Martin
  • Blechar, Julius
  • Böckmann, Anja
  • Brigandat, Louis
  • Bula, Anna
  • Bütikofer, Matthias
  • Camacho-Zarco, Aldo R.
  • Ghosh, Dhiman
  • Carlomagno, Teresa
  • Caruso, Icaro Putinhon
  • Ceylan, Betül
  • Chaikuad, Apirat
  • Chu, Feixia
  • Cole, Laura
  • Crosby, Marquise G.
  • Jesus, Vanessa de
  • Dhamotharan, Karthikeyan
  • Felli, Isabella C.
  • Gomes-Neto, Francisco
  • Ferner, Jan
  • Fleischmann, Yanick
  • Fogeron, Marie-Laure
  • Fourkiotis, Nikolaos K.
  • Fuks, Christin
  • Fürtig, Boris
  • Gallo, Angelo
  • Gande, Santosh L.
  • Gerez, Juan Atilio
  • Gorbatyuk, Oksana
  • Guseva, Serafima
  • Hacker, Carolin
  • Häfner, Sabine
  • Hao, Bing
  • Hargittay, Bruno
  • Henzler-Wildman, K.
  • Hoch, Jeffrey C.
  • Malki, Anas
  • Hohmann, Katharina F.
  • Hutchison, Marie T.
  • Jaudzems, Kristaps
  • Jović, Katarina
  • Kaderli, Janina
  • Kalniņš, Gints
  • Kaņepe, Iveta
  • Kirchdoerfer, Robert N.
  • Kirkpatrick, John
  • Knapp, Stefan
  • Bessa, Luiza Mamigonian
  • Krishnathas, Robin
  • Kutz, Felicitas
  • Lage, Susanne zur
  • Lambertz, Roderick
  • Lang, Andras
  • Laurents, Douglas V.
  • Lecoq, Lauriane
  • Linhard, Verena
  • Löhr, Frank
  • Martin, Rachel W.
  • Matzel, Tobias
  • Maurin, Damien
  • McNutt, Seth W.
  • Mebus-Antunes, Nathane Cunha
  • Meier, Beat H.
  • Meiser, Nathalie
  • Mompeán, Miguel
  • Pinheiro, Anderson S..
  • Monaca, Elisa
  • Montserret, Roland
  • Mariño Perez, Laura
  • Moser, Celine
  • Muhle-Goll, Claudia
  • Neves-Martins, Thais Cristtina
  • Ni, Xiamonin
  • Norton-Baker, Brenna
  • Pierattelli, Roberta
  • Pontoriero, Letizia
  • Sabbatella, Raffaele
  • Pustovalova, Yulia
  • Ohlenschläger, Oliver
  • Orts, Julien
  • Poian, Andrea T. da
  • Pyper, Dennis J.
  • Richter, Christian
  • Riek, Roland
  • Rienstra, Chad M.
  • Robertson, Angus
  • Salvi, Nicola
  • Saxena, Krishna
  • Schulte, Linda
  • Schiavina, Marco
  • Schwalbe, Harald
  • Silber, Mara
  • Silva Almeida, Marcius da
  • Sprague-Piercy, Marc A.
  • Anderson, Thomas K.
  • Spyroulias, Georgios A.
  • Sreeramulu, Sridhar
  • Tants, Jan-Niklas
  • Tārs, Kaspars
  • Torres, Felix
  • Töws, Sabrina
  • Treviño, Miguel A.
  • Trucks, Sven
  • Tsika, Aikaterini C.
  • Varga, Krisztina
  • Anobom, Cristiane D.
  • Wang, Ying
  • Weber, Marco E.
  • Weigand, Julia E.
  • Wiedemann, Christoph
  • Wirmer-Bartoschek, Julia
  • Wirtz Martin, Maria Alexandra
  • Zehnder, Johannes
  • Hengesbach, Martin
  • Schlundt, Andreas
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form., This work was supported by Goethe University (Corona funds), the DFG-funded CRC: “Molecular Principles of RNA-Based Regulation,” DFG infrastructure funds (project numbers: 277478796, 277479031, 392682309, 452632086, 70653611), the state of Hesse (BMRZ), the Fondazione CR Firenze (CERM), and the IWB-EFRE-program 20007375. This project has received funding from the European Union’s Horizon 2020 research and innovation program under Grant Agreement No. 871037. AS is supported by DFG Grant SCHL 2062/2-1 and by the JQYA at Goethe through project number 2019/AS01. Work in the lab of KV was supported by a CoRE grant from the University of New Hampshire. The FLI is a member of the Leibniz Association (WGL) and financially supported by the Federal Government of Germany and the State of Thuringia. Work in the lab of RM was supported by NIH (2R01EY021514) and NSF (DMR-2002837). BN-B was supported by theNSF GRFP.MCwas supported byNIH (R25 GM055246 MBRS IMSD), and MS-P was supported by the HHMI Gilliam Fellowship. Work in the labs of KJ and KT was supported by Latvian Council of Science Grant No. VPP-COVID 2020/1-0014. Work in the UPAT’s lab was supported by the INSPIRED (MIS 5002550) project, which is implemented under the Action “Reinforcement of the Research and Innovation Infrastructure,” funded by the Operational Program “Competitiveness, Entrepreneurship and Innovation” (NSRF 2014–2020) and cofinanced by Greece and the EU (European Regional Development Fund) and the FP7 REGPOT CT-2011- 285950–“SEE-DRUG” project (purchase of UPAT’s 700MHz NMR equipment). Work in the CM-G lab was supported by the Helmholtz society. Work in the lab of ABö was supported by the CNRS, the French National Research Agency (ANR, NMRSCoV2- ORF8), the Fondation de la Recherche Médicale (FRM, NMR-SCoV2-ORF8), and the IR-RMN-THC Fr3050 CNRS. Work in the lab of BM was supported by the Swiss National Science Foundation (Grant number 200020_188711), the Günthard Stiftung für Physikalische Chemie, and the ETH Zurich. Work in the labs of ABö and BM was supported by a common grant from SNF (grant 31CA30_196256). This work was supported by the ETHZurich, the grant ETH40 18 1, and the grant Krebsliga KFS 4903 08 2019. Work in the lab of the IBS Grenoble was supported by the Agence Nationale de Recherche (France) RA-COVID SARS2NUCLEOPROTEIN and European Research Council Advanced Grant DynamicAssemblies. Work in the CA lab was supported by Patto per il Sud della Regione Siciliana–CheMISt grant (CUP G77B17000110001). Part of this work used the platforms of the Grenoble Instruct-ERIC center (ISBG; UMS 3518 CNRS-CEA-UGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB), supported by FRISBI (ANR-10-INBS-05-02) and GRAL, financed within the University Grenoble Alpes graduate school (Ecoles Universitaires de Recherche) CBH-EUR-GS (ANR-17-EURE- 0003). Work at the UW-Madison was supported by grant numbers NSF MCB2031269 and NIH/NIAID AI123498. MM is a Ramón y Cajal Fellow of the Spanish AEI-Ministry of Science and Innovation (RYC2019-026574-I), and a “La Caixa” Foundation (ID 100010434) Junior Leader Fellow (LCR/BQ/PR19/11700003). Funded by project COV20/00764 fromthe Carlos III Institute of Health and the SpanishMinistry of Science and Innovation to MMand DVL. VDJ was supported by the Boehringer Ingelheim Fonds. Part of this work used the resources of the Italian Center of Instruct-ERIC at the CERM/ CIRMMP infrastructure, supported by the Italian Ministry for University and Research (FOE funding). CF was supported by the Stiftung Polytechnische Gesellschaft. Work in the lab of JH was supported by NSF (RAPID 2030601) and NIH (R01GM123249)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation

  • Ginex, Tiziana
  • Marco-Marín, Clara
  • Wieczor, Milosz
  • Mata, Carlos P.
  • Krieger, James
  • López-Redondo, Marisa
  • Francés-Gómez, Clara
  • Ruiz-Rodríguez, Paula
  • Melero, Roberto
  • Sorzano, Carlos Óscar S.
  • Martínez, Marta
  • Gougeard, Nadine
  • Forcada-Nadal, Alicia
  • Zamora-Caballero, Sara
  • Gozalbo-Rovira, Roberto
  • Sanz-Frasquet, Carla
  • Bravo, Jerónimo
  • Rubio, Vicente
  • Marina, Alberto
  • Geller, Ron
  • Comas, Iñaki
  • Gil, Carmen
  • Coscollá, Mireia
  • Orozco, Modesto
  • Llácer, José Luis
  • Carazo, José M.
The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has now reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness., This research work was supported by the European Commission–NextGenerationEU through the CSIC Global Health Platform. Additionally, authors would like to acknowledge economic support from the Spanish Ministry of Science and Innovation through Grants: PID2019-104757RB-I00 funded by MCIN/AEI/ 10.13039/501100011033, RTI2018-094399-A-I00, and “ERDF A way of making Europe”, by the “European Union”, Grant SEV 2017-0712 funded by MCIN/AEI /10.13039/501100011033, the “Comunidad Autónoma de Madrid" through Grant: S2017/BMD3817, and the European Union (EU) and Horizon 2020 through grants: Marie-Curie Fellowship EnLaCES (MSCA IF 2020, Proposal: 101024130) (to JK), HighResCells (ERC - 2018 - SyG, Proposal: 810057), and iNEXT-Discovery (Proposal: 871037). AM, VR, JB and JLL are funded by CIBERER-ISCIII (proposal: COV20/00437), Fondo Supera COVID-19 (proposal: CSICCOVID19-082), Banco Santander (Proposal: BlockAce), and CSIC PTI Salud Global (Proposal: 202080E110). VR is funded by the Spanish Ministry of Science and Innovation through Grant PID2020-120322RB-C21. IC is funded by project PID2019-104477RB-100, Fondo COVID COV20/00140 and ERC CoG 101001038. MC is funded by the RyC program from the Spanish Ministry of Science and Innovation, the Generalitat Valenciana (SEJI/2019/011)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development

  • Berg, Hannes
  • Wirtz Martin, Maria A.
  • Altincekic, Nadide
  • Alshamleh, Islam
  • Kaur Bains, Jasleen
  • Blechar, Julius
  • Ceylan, Betül
  • Jesus, Vanessa de
  • Dhamotharan, Karthikeyan
  • Fuks, Christin
  • Gande, Santosh L.
  • Hargittay, Bruno
  • Hohmann, Katharina F.
  • Hutchison, Marie T.
  • Marianne Korn, Sophie
  • Krishnathas, Robin
  • Kutz, Felicitas
  • Linhard, Verena
  • Matzel, Tobias
  • Meiser, Nathalie
  • Niesteruk, Anna
  • Pyper, Dennis J.
  • Schulte, Linda
  • Trucks, Sven
  • Azzaoui, Kamal
  • Blommers, Marcel J.J.
  • Gadiya, Yojana
  • Karki, Reagon
  • Zaliani, Andrea
  • Gribbon, Philip
  • da Silva Almeida, Marcius
  • Dinis Anobom, Cristiane
  • Bula, Anna L.
  • Bütikofer, Matthias
  • Putinhon Caruso, Ícaro
  • Caterina Felli, Isabella
  • Poian, Andrea T. da
  • Cardoso de Amorim, Gisele
  • Fourkiotis, Nikolaos K.
  • Gallo, Angelo
  • Ghosh, Dhiman
  • Gomes-Neto, Francisco
  • Gorbatyuk, Oksana
  • Hao, Bing
  • Kurauskas, Vilius
  • Lecoq, Lauriane
  • Li, Yunfeng
  • Cunha Mebus-Antunes, Nathane
  • Mompeán, Miguel
  • Cristtina Neves-Martins, Thais
  • Ninot-Pedrosa, Martí
  • Pinheiro, Anderson S..
  • Pontoriero, Letizia
  • Pustovalova, Yulia
  • Riek, Roland
  • Robertson, Angus J.
  • Jose Abi Saad, Marie
  • Treviño, Miguel A.
  • Tsika, Aikaterini C.
  • Almeida, Fabio C.L.
  • Bax, Ad
  • Henzler-Wildman, Katherine
  • Hoch, Jeffrey C.
  • Jaudzems, Kristaps
  • Laurents, Douglas V.
  • Orts, Julien
  • Pierattelli, Roberta
  • Spyroulias, Georgios A.
  • Duchardt-Ferner, Elke
  • Ferner, Jan
  • Fürtig, Boris
  • Hengesbach, Martin
  • Löhr, Frank
  • Qureshi, Nusrat
  • Richter, Christian
  • Saxena, Krishna
  • Schlundt, Andreas
  • Sreeramulu, Sridhar
  • Wacker, Anna
  • Weigand, Julia E.
  • Wirmer-Bartoschek, Julia
  • Wöhnert, Jens
  • Schwalbe, Harald
12 pags., 4 figs., 3 tabs., SARS-CoV-2 (SCoV2) and its variants of concern pose serious challenges to the public health. The variants increased challenges to vaccines, thus necessitating for development of new intervention strategies including anti-virals. Within the international Covid19-NMR consortium, we have identified binders targeting the RNA genome of SCoV2. We established protocols for the production and NMR characterization of more than 80 % of all SCoV2 proteins. Here, we performed an NMR screening using a fragment library for binding to 25 SCoV2 proteins and identified hits also against previously unexplored SCoV2 proteins. Computational mapping was used to predict binding sites and identify functional moieties (chemotypes) of the ligands occupying these pockets. Striking consensus was observed between NMR-detected binding sites of the main protease and the computational procedure. Our investigation provides novel structural and chemical space for structure-based drug design against the SCoV2 proteome., Work at BMRZ is supported by the state of Hesse. Work in Covid19-NMR was supported by the Goethe Corona Funds, by the IWBEFRE-program 20007375 of state of Hesse, the DFG through CRC902: “Molecular Principles of RNA-based regulation.” and through infrastructure funds (project numbers: 277478796, 277479031, 392682309, 452632086, 70653611) and by European Union’s Horizon 2020 research and innovation program iNEXT-discovery under grant agreement No 871037. BY-COVID receives funding from the European Union’s Horizon Europe Research and Innovation Programme under grant agreement number 101046203. “INSPIRED” (MIS 5002550) project, implemented under the Action “Reinforcement of the Research and Innovation Infrastructure,” funded by the Operational Program “Competitiveness, Entrepreneurship and Innovation” (NSRF 2014–2020) and co-financed by Greece and the EU (European Regional Development Fund) and the FP7 REGPOT CT-2011-285950—“SEE-DRUG” project (purchase of UPAT’s 700 MHz NMR equipment). The support of the CERM/CIRMMP center of Instruct-ERIC is gratefully acknowledged. This work has been funded in part by a grant of the Italian Ministry of University and Research (FISR2020IP_02112, ID-COVID) and by Fondazione CR Firenze. A.S. is supported by the Deutsche Forschungsgemeinschaft [SFB902/B16, SCHL2062/2-1] and the Johanna Quandt Young Academy at Goethe [2019/AS01]. M.H. and C.F. thank SFB902 and the Stiftung Polytechnische Gesellschaft for the Scholarship. L.L. work was supported by the French National Research Agency (ANR, NMR-SCoV2-ORF8), the Fondation de la Recherche Médicale (FRM, NMR-SCoV2-ORF8), FINOVI and the IR-RMN-THC Fr3050 CNRS. Work at UConn Health was supported by grants from the US National Institutes of Health (R01 GM135592 to B.H., P41 GM111135 and R01 GM123249 to J.C.H.) and the US National Science Foundation (DBI 2030601 to J.C.H.). Latvian Council of Science Grant No. VPP-COVID-2020/1-0014. National Science Foundation EAGER MCB-2031269. This work was supported by the grant Krebsliga KFS-4903-08-2019 and SNF-311030_192646 to J.O. P.G. (ITMP) The EOSC Future project is co-funded by the European Union Horizon Programme call INFRAEOSC-03-2020—Grant Agreement Number 101017536. Open Access funding enabled and organized by Projekt DEAL, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Scipion-EM-ProDy: A Graphical Interface for the ProDy Python Package within the Scipion Workflow Engine Enabling Integration of Databases, Simulations and Cryo-Electron Microscopy Image Processing

  • Krieger, James
  • Sorzano, Carlos Óscar S.
  • Carazo, José M.
Macromolecular assemblies, such as protein complexes, undergo continuous structural dynamics, including global reconfigurations critical for their function. Two fast analytical methods are widely used to study these global dynamics, namely elastic network model normal mode analysis and principal component analysis of ensembles of structures. These approaches have found wide use in various computational studies, driving the development of complex pipelines in several software packages. One common theme has been conformational sampling through hybrid simulations incorporating all-atom molecular dynamics and global modes of motion. However, wide functionality is only available for experienced programmers with limited capabilities for other users. We have, therefore, integrated one popular and extensively developed software for such analyses, the ProDy Python application programming interface, into the Scipion workflow engine. This enables a wider range of users to access a complete range of macromolecular dynamics pipelines beyond the core functionalities available in its command-line applications and the normal mode wizard in VMD. The new protocols and pipelines can be further expanded and integrated into larger workflows, together with other software packages for cryo-electron microscopy image analysis and molecular simulations. We present the resulting plugin, Scipion-EM-ProDy, in detail, highlighting the rich functionality made available by its development., Funding is acknowledged from the Ministry of Science and Innovation through grant PID2019-104757RB-I00 funded by MCIN/AEI/10.13039/501100011033/; the Comunidad Autonoma de Madrid through grant S2022/BMD-7232; and the European Union (EU) and Horizon 2020 through grants EnLaCES (H2020-MSCA-IF-2020, Proposal: 101024130 to JMK), HighResCells (ERC-2018-SyG, Proposal: 810057) and iNEXT-Discovery (Proposal: 871037) and the framework “ERDF A way of making Europe”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The CCP4 suite: integrative software for macromolecular crystallography

  • Agirre, Jon
  • Atanasova, Mihaela
  • Bagdonas, Haroldas
  • Ballard, Charles B.
  • Basle, A.
  • Beilsten-Edmands, James
  • Borges, Rafael J.
  • Brown, D. G.
  • Burgos-Mármol, J. Javier
  • Berrisford, J.
  • Bond, Paul S.
  • Caballero, Iracema
  • Catapano, Lucrezia
  • Chojnowski, G.
  • Cook, Atlanta G.
  • Cowtan, K.
  • Croll, Tristan I.
  • Debreczeny, Judith E.
  • Devenish, Nicholas E.
  • Dodson, Eleanor J.
  • Drevon, Tarik R.
  • Emsley, Paul
  • Evans, Gwyndaf
  • Evans, Phil R.
  • Fando, M.
  • Foadi, James
  • Fuentes-Montero, Luis
  • Garman, Elspeth F.
  • Gerstel, Markus
  • Gildea, Richard J.
  • Hatti, Kaushik
  • Hekkelman, Maarten L.
  • Heuser, Philipp
  • Wen Hoh, Soon
  • Hough, Michael A.
  • Jenkins, Huw T.
  • Jiménez, Elisabet
  • Joosten, Robbie P.
  • Keegan, R. M.
  • Keep, Nicholas
  • Krissinel, E.
  • Kolenko, Petr
  • Kovalevskiy, O.
  • Lamzin, V.
  • Lawson, David M.
  • Lebedev, Andrey
  • Leslie, A. G. W.
  • Lohkamp, B.
  • Long, Fei
  • Maly, Martin
  • McCoy, Airlie J.
  • McNicholas, S.
  • Medina, Ana
  • Millán, Claudia
  • Murray, James W.
  • Murshudov, Garib
  • Nicholls, R. A.
  • Noble, Martin E. M.
  • Oeffner, Robert D.
  • Pannu, Navraj S.
  • Parkhurst, James M.
  • Pearce, Nicholas
  • Pereira, Joana
  • Perrakis, Anastassis
  • Powell, Harold R.
  • Read, Randy J.
  • Rigden, D. J.
  • Rochira, William
  • Sammito, Massimo
  • Sánchez Rodríguez, Filomeno
  • Sheldrick, George M.
  • Shelley, Kathryn L.
  • Simkovic, Felix
  • Simpkin, A. J.
  • Skubák, P.
  • Sobolev, Egor
  • Steiner, Roberto A.
  • Stevenson, Kyle
  • Tews, I.
  • Thomas, J. M. H.
  • Thorn, Andrea
  • Triviño, Josep
  • Uski, V.
  • Usón, Isabel
  • Vagin, Alexei
  • Velankar, Sameer
  • Vollmar, Melanie
  • Walden, Helen
  • Waterman, David
  • Wilson, Keith S.
  • Winn, Martyn D.
  • Winter, Graeme
  • Wojdyr, M.
  • Yamashita, Keitaro
The Collaborative Computational Project No. 4 (CCP4) is a UK-led international collective with a mission to develop, test, distribute and promote software for macromolecular crystallography. The CCP4 suite is a multiplatform collection of programs brought together by familiar execution routines, a set of common libraries and graphical interfaces. The CCP4 suite has experienced several considerable changes since its last reference article, involving new infrastructure, original programs and graphical interfaces. This article, which is intended as a general literature citation for the use of the CCP4 software suite in structure determination, will guide the reader through such transformations, offering a general overview of the new features and outlining future developments. As such, it aims to highlight the individual programs that comprise the suite and to provide the latest references to them for perusal by crystallographers around the world., Jon Agirre is a Royal Society University Research Fellow (UF160039 and URF\R\221006). Mihaela Atanasova is funded by the UK Engineering and Physical Sciences Research Council (EPSRC; EP/R513386/1). Haroldas Bagdonas is funded by The Royal Society (RGF/R1/181006). Jose´ Javier Burgos-Ma´rmol and Daniel J. Rigden are supported by the BBSRC (BB/S007105/1). Robbie P. Joosten is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 871037 (iNEXTDiscovery) and by CCP4. This work was supported by the Medical Research Council as part of United Kingdom Research and Innovation, also known as UK Research and Innovation: MRC file reference No. MC_UP_A025_1012 to Garib N. Murshudov, which also funded Keitaro Yamashita, Paul Emsley and Fei Long. Robert A. Nicholls is funded by the BBSRC (BB/S007083/1). Soon Wen Hoh is funded by the BBSRC (BB/T012935/1). Kevin D. Cowtan and Paul S. Bond are funded in part by the BBSRC (BB/S005099/1). John Berrisford and Sameer Velankar thank the European Molecular Biology Laboratory–European Bioinformatics Institute, who supported this work. Andrea Thorn was supported in the development of AUSPEX by the German Federal Ministry of Education and Research (05K19WWA and 05K22GU5) and by Deutsche Forschungsgemeinschaft (TH2135/2-1). Petr Kolenko and Martin Maly´ are funded by the MEYS CR (CZ.02.1.01/0.0/0.0/16_019/0000778). Martin Maly´ is funded by the Czech Academy of Sciences (86652036) and CCP4/STFC (521862101). Anastassis Perrakis acknowledges funding from iNEXT (grant No. 653706), iNEXT-Discovery (grant No. 871037), West-Life (grant No. 675858) and EOSC-Life (grant No. 824087) funded by the Horizon 2020 program of the European Commission. Robbie P. Joosten has been the recipient of a Veni grant (722.011.011) and a Vidi grant (723.013.003) from the Netherlands Organization for Scientific Research (NWO). Maarten L. Hekkelman, Robbie P. Joosten and Anastassis Perrakis thank the Research High Performance Computing facility of the Netherlands Cancer Institute for providing and maintaining computation resources and acknowledge the institutional grant from the Dutch Cancer Society and the Dutch Ministry of Health, Welfare and Sport. Tarik R. Drevon is funded by the BBSRC (BB/S007040/1). Randy J. Read is supported by a Principal Research Fellowship from the Wellcome Trust (grant 209407/Z/17/Z). Atlanta G. Cook is supported by a Wellcome Trust SRF (200898) and a Wellcome Centre for Cell Biology core grant (203149). Isabel Uso´n acknowledges support from STFC-UK/CCP4: ‘Agreement for the integration of methods into the CCP4 software distribution, ARCIMBOLDO_LOW’ and Spanish MICINN/AEI/FEDER/UE (PID2021-128751NB-I00). Pavol Skubak and Navraj Pannu were funded by the NWO Applied Sciences and Engineering Domain and CCP4 (grant Nos. 13337 and 16219). Bernhard Lohkamp was supported by the Ro¨ntgen A˚ ngstro¨m Cluster (grant 349-2013-597). Nicholas Pearce is currently funded by the SciLifeLab and Wallenberg Data Driven Life Science Program (grant KAW 2020.0239) and has previously been funded by a Veni Fellowship (VI.Veni.192.143) from the Dutch Research Council (NWO), a Long-term EMBO fellowship (ALTF 609-2017) and EPSRC grant EP/G037280/1. David M. Lawson received funding from BBSRC Institute Strategic Programme Grants (BB/P012523/1 and BB/P012574/1). Lucrezia Catapano is the recipient of an STFC/CCP4-funded PhD studentship (Agreement No: 7920 S2 2020 007)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Fijivirus Major Viroplasm Protein Shows RNA-Stimulated ATPase Activity by Adopting Pentameric and Hexameric Assemblies of Dimers

  • Llauger, Gabriela
  • Melero, Roberto
  • Monti, Demián
  • Sycz, Gabriela
  • Huck-Iriart, Cristián
  • Cerutti, María L
  • Klinke, Sebastián
  • Mikkelsen, Evelyn
  • Tijman, Ariel
  • Arranz, Rocío
  • Alfonso, Victoria
  • Arellano, Sofía M
  • Goldbaum, Fernando A
  • Sterckx, Yann G J
  • Carazo, José M.
  • Kaufman, Sergio B
  • Dans, Pablo D
  • Del Vas, Mariana
  • Otero, Lisandro H.
Material suplementario: https://figshare.com/articles/media/mBIO-Llauger-et-al-2023-movieS1/21842169 https://figshare.com/articles/media/mBIO-Llauger-et-al-2023-movieS2/21842298 https://figshare.com/articles/media/mBIO-Llauger-et-al-2023-movieS3/21858138, Fijiviruses replicate and package their genomes within viroplasms in a process involving RNA-RNA and RNA-protein interactions. Here, we demonstrate that the 24 C-terminal residues (C-arm) of the P9-1 major viroplasm protein of the mal de Río Cuarto virus (MRCV) are required for its multimerization and the formation of viroplasm-like structures. Using an integrative structural approach, the C-arm was found to be dispensable for P9-1 dimer assembly but essential for the formation of pentamers and hexamers of dimers (decamers and dodecamers), which favored RNA binding. Although both P9-1 and P9-1ΔC-arm catalyzed ATP with similar activities, an RNA-stimulated ATPase activity was only detected in the full-length protein, indicating a C-arm-mediated interaction between the ATP catalytic site and the allosteric RNA binding sites in the (do)decameric assemblies. A stronger preference to bind phosphate moieties in the decamer was predicted, suggesting that the allosteric modulation of ATPase activity by RNA is favored in this structural conformation. Our work reveals the structural versatility of a fijivirus major viroplasm protein and provides clues to its mechanism of action. IMPORTANCE The mal de Río Cuarto virus (MRCV) causes an important maize disease in Argentina. MRCV replicates in several species of Gramineae plants and planthopper vectors. The viral factories, also called viroplasms, have been studied in detail in animal reovirids. This work reveals that a major viroplasm protein of MRCV forms previously unidentified structural arrangements and provides evidence that it may simultaneously adopt two distinct quaternary assemblies. Furthermore, our work uncovers an allosteric communication between the ATP and RNA binding sites that is favored in the multimeric arrangements. Our results contribute to the understanding of plant reovirids viroplasm structure and function and pave the way for the design of antiviral strategies for disease control., his work was supported by the Argentinean Ministry of Science and Technology (MINCyT), the Argentinean Research Council (CONICET), and the National Agency for the Promotion of Science and Technology of Argentina (ANPCyT) under grants PICT 2014-3754, PICT 2015-0621, PICT 2016-1425, PICT 2017-2537, and PICT 2017-3150. We acknowledge the support of the European Union (EU) and Horizon 2020 through the iNEXT-Discovery Proposal 871037 (access project PID: 5391), the support and the use of resources of Instruct, a Landmark ESFRI project (specifically Instruct Access Project PID: 5526), and CRIOMECORR project (ESFRI-2019-01-CSIC-16) to the cryo-EM facility of the CNB (Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

In-cell NMR suggests that DNA i-motif levels are strongly depleted in living human cells

  • Víšková, Pavlína
  • Ištvánková, Eva
  • Ryneš, Jan
  • Džatko, Šimon
  • Loja, Tomáš
  • Živković, Martina Lenarčič
  • Rigo, Riccardo
  • El-Khoury, Roberto
  • Serrano-Chacón, Israel
  • Damha, Masad J.
  • González, Carlos
  • Mergny, Jean-Louis
  • Foldynová-Trantírková, Silvie
  • Trantírek, Lukáš
12 pags., 2 figs., 2 tabs., I-Motifs (iM) are non-canonical DNA structures potentially forming in the accessible, single-stranded, cytosine-rich genomic regions with regulatory roles. Chromatin, protein interactions, and intracellular properties seem to govern iM formation at sites with i-motif formation propensity (iMFPS) in human cells, yet their specific contributions remain unclear. Using in-cell NMR with oligonucleotide iMFPS models, we monitor iM-associated structural equilibria in asynchronous and cell cycle-synchronized HeLa cells at 37 °C. Our findings show that iMFPS displaying pHT < 7 under reference in vitro conditions occur predominantly in unfolded states in cells, while those with pHT > 7 appear as a mix of folded and unfolded states depending on the cell cycle phase. Comparing these results with previous data obtained using an iM-specific antibody (iMab) reveals that cell cycle-dependent iM formation has a dual origin, and iM formation concerns only a tiny fraction (possibly 1%) of genomic sites with iM formation propensity. We propose a comprehensive model aligning observations from iMab and in-cell NMR and enabling the identification of iMFPS capable of adopting iM structures under physiological conditions in living human cells. Our results suggest that many iMFPS may have biological roles linked to their unfolded states., This project was supported by grants from the Czech Science Foundation (GX19–26041X to L.T.), European Regional Development Fund, with financial contribution from MEYS CR (SYMBIT: CZ.02.1.01/0.0/0.0/15_003/0000477 to S.F.T. and J.L.M.), MSCAfellow2@MUNI to R.R. [CZ.02.2.69/0.0/0.0/20_079/0017045]), European Union—Next Generation EU (project National Institute for Cancer Research; Program EXCELES, ID Project No. LX22NPO5102 to S.F.T.), ANR grant [ANR-21-CE44-0005-01] ‘ICARE’ to J.L.M., and the National Science and Engineering Research Council of Canada (Discovery Grant to M.J.D.). The authors also acknowledge the institutional projects enabling access to research infrastructure: APPID (815) financed by Instruct, iNEXT-Discovery [871037] financed by Horizon 2020 program of the European Commission, Josef Dadok National NMR Center of CIISB, Instruct-CZ Center, supported by MEYS CR (LM2023042) and European Regional Development Fund-Project „UP CIISB“ (No. CZ.02.1.01/0.0/0.0/18_046/0015974), core facility CELLIM supported by MEYS CR (LM2023050 Czech-BioImaging), and the Flow Cytometry Laboratory at CEITEC MU supported by the EATRIS-ERIC-CZ research infrastructure (LM2023053 funded by MEYS CR). Disclaimer: the iNEXT-Discovery project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 871037. This publication reflects only the author’s view, and the Research Executive Agency/ the European Commission is not responsible for any use that may be made of the information it contains., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural and biochemical characterization of the C-terminal region of the human RTEL1 helicase

  • Cortone, Giuseppe
  • Graewert, Melissa A.
  • Kanade, Manil
  • Longo, Antonio
  • Hegde, Raghurama
  • González-Magaña, Amaia
  • Chaves-Arquero, Belén
  • Blanco, Francisco J.
  • Napolitano, Luisa M. R.
  • Onesti, Silvia
18 p.-5 fig.-2 tab., RTEL1 is an essential DNA helicase which plays an important role in various aspects of genome stability, from telomere metabolism to DNA replication, repair and recombination. RTEL1 has been implicated in a number of genetic diseases and cancer development, including glioma, breast, lung and gastrointestinal tumors. RTEL1 is a FeS helicase but, in addition to the helicase core, it comprises a long C-terminal region which includes a number of folded domains connected by intrinsically disordered loops and mediates RTEL1 interaction with factors involved in pivotal cellular pathways. However, information on the architecture and the function of this region is still limited. We expressed and purified a variety of fragments encompassing the folded domains and the unstructured regions. We determined the crystal structure of the second repeat, confirming that it has a fold similar to the harmonin homology domains. SAXS data provide low-resolution information on all the fragments and suggest that the presence of the RING domain affects the overall architecture of the C-terminal region, making the structure significantly more compact. NMR data provide experimental information on the interaction between PCNA and the RTEL1 C-terminal region, revealing a putative low-affinity additional site of interaction. A biochemical analysis shows that the C-terminal region, in addition to a preference for telomeric RNA and DNA G-quadruplexes, has a high affinity for R-loops and D-loops, consistent with the role played by the RTEL1 helicase in homologous recombination, telomere maintenance and preventing replication-transcription conflicts. We further dissected the contribution of each domain in binding different substrates., This work was supported by the Fondazione Italiana per la Ricerca sul Cancro, through grant IG 20778. The project also received funds from the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement no. 859853 (AntiHelix). SAXS data collection has been supported by iNEXT-Discovery, grant number 871037, funded by the Horizon 2020 program of the European Commission. Work at CIB-CSIC has been supported by MCIN/AEI/10.13039/501100011033 (PID2020-113225GB-I00 to FJB). AL gratefully acknowledges CERIC-ERIC for funding within the framework of INTEGRA and INTEGRA's PhD project., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Amyloid-like DNA bridging: a new mode of DNA shaping

  • Wien, Frank
  • Gragera, Marcos
  • Matsuo, Tatsuhito
  • Moroy, Gautier
  • Bueno-Carrasco, María Teresa
  • Arranz, Rocío
  • Cossa, Antoine
  • Martel, Anne
  • Bordallo, Heloisa N
  • Rudić, Svemir
  • Velez, Marisela
  • van der Maarel, Johan R C
  • Peters, Judith
  • Arluison, Véronique
Supplementary data is available at NAR online, All organisms depend on specific proteins to compact and organize their genomes. In eukaryotes, histones fulfil this role, while bacterial chromosomes are shaped by nucleoid-associated proteins (NAPs). Among its pleiotropic functions, the NAP Hfq plays a pivotal role in bacterial genome organization. In this study, we characterized the structure of the C-terminal extension of Hfq, which mediates chromosomal compaction, in its DNA-bound state. Using an integrative approach that combined transmission electron microscopy, neutron scattering, site-directed mutagenesis, and molecular modeling, we identified an amyloid module formed by the C-terminal region of Hfq. This module uniquely bridges and compacts six DNA molecules, marking the first documented instance of an amyloid structure with DNA-bridging properties. Our findings redefine the functional landscape of amyloids, linking them to genome architecture and gene regulation. This result suggests that amyloid-DNA interactions may represent a conserved mechanism across biological systems, with profound implications for understanding genome organization and the regulation of gene expression in both prokaryotes and eukaryotes., The authors acknowledge the support of the European Union (EU) and Horizon 2020 through the iNEXT-Discovery Proposal (871037, Access Project PID: 19663), as well as the CRIOMECORR project (ESFRI-2019-01-CSIC-16) for access to the CryoEM CNB-CSIC facility, and in particular, the assistance of Noelia Zamarre\u00F1o. This work also benefited from access to the Instruct Image Processing Centre, an Instruct-ERIC centre, with financial support provided by Instruct-ERIC (PID 23014). We are thankful to ILL (Grenoble, France) for attribution of beamtime (proposal 85028). We gratefully acknowledge the Science and Technology Facilities Council (STFC) for access to TOSCA neutron beamtime at ISIS, as well as for the provision of sample preparation (proposal RB2000225)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

GluA4 AMPA receptor gating mechanisms and modulation by auxiliary proteins

  • Vega-Gutiérrez, Carlos
  • Picañol-Párraga, Javier
  • Sánchez-Valls, Irene
  • Ribón-Fuster, Victoria del Pilar
  • Soto, David
  • Herguedas, Beatriz
AMPA-type glutamate receptors, fundamental ion channels for fast excitatory neurotransmission and synaptic plasticity, contain a GluA tetrameric core surrounded by auxiliary proteins such as transmembrane AMPA receptor regulatory proteins (TARPs) or Cornichons. Their exact composition and stoichiometry govern functional properties, including kinetics, calcium permeability and trafficking. The GluA1–GluA3 subunits predominate in the adult forebrain and are well characterized. However, we lack structural information on full-length GluA4-containing AMPARs, a subtype that has specific roles in brain development and specific cell types in mammals. Here we present the cryo-electron microscopy structures of rat GluA4:TARP-γ2 trapped in active, resting and desensitized states, covering a full gating cycle. Additionally, we describe the structure of GluA4 alone, which displays a classical Y-shaped conformation. In resting conditions, GluA4:TARP-γ2 adopts two conformations, one resembling the desensitized states of other GluA subunits. Moreover, we identify a regulatory site for TARP-γ2 in the ligand-binding domain that modulates gating kinetics. Our findings uncover distinct features of GluA4, highlighting how subunit composition and auxiliary proteins shape receptor structure and dynamics, expanding glutamatergic signaling diversity.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Advances in xmipp for cryo-electron microscopy: From xmipp to scipion

  • Strelak, David
  • Jiménez-Moreno, Amaya
  • Vilas, José L.
  • Ramírez-Aportela, Erney
  • Sánchez-García, Rubén
  • Maluenda Niubó, David
Xmipp is an open-source software package consisting of multiple programs for processing data originating from electron microscopy and electron tomography, designed and managed by the Biocomputing Unit of the Spanish National Center for Biotechnology, although with contributions from many other developers over the world. During its 25 years of existence, Xmipp underwent multiple changes and updates. While there were many publications related to new programs and functionality added to Xmipp, there is no single publication on the Xmipp as a package since 2013. In this article, we give an overview of the changes and new work since 2013, describe technologies and techniques used during the development, and take a peek at the future of the package.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

  • Ginex, Tiziana
  • Marco Marín, Clara
  • Wieczór, Miłosz
  • Mata, Carlos P.
  • Krieger, James
  • Ruiz Rodriguez, Paula
  • López Redondo, Maria Luisa
  • Francés Gómez, Clara
  • Melero, Roberto
  • Sánchez Sorzano, Carlos Óscar
  • Martínez, Marta
  • Gougeard, Nadine
  • Forcada Nadal, Alicia
  • Zamora Caballero, Sara
  • Gozalbo Rovira, Roberto
  • Sanz Frasquet, Carla
  • Arranz, Rocío
  • Bravo, Jeronimo
  • Rubio, Vicente
  • Marina, Alberto
  • Geller, Ron
  • Comas, Iñaki
  • Gil, Carmen
  • Coscolla, Mireia
  • Orozco López, Modesto
  • Llácer, José Luis
  • Carazo, Jose Maria
  • The IBV Covid19 Pipeline
The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has since reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness.